Maggot chymotrypsin i from Lucilia sericata is resistant to endogenous wound protease inhibitors

British Journal of Dermatology

Volumn 164, Issue 1, 2011, Pages 192-196

  Telford, G ^a   Brown, A P ^a   Kind, A ^b   English, J S C ^b   Pritchard, D I ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; CHYMOTRYPSIN; COUMARIN DERIVATIVE; PROTEINASE INHIBITOR; RECOMBINANT CHYMOTRYPSIN; UNCLASSIFIED DRUG;

ARTHROPOD; ARTICLE; DEBRIDEMENT; DRUG INHIBITION; DRUG SENSITIVITY; ENZYME ACTIVITY; LUCILIA SERICATA; MAGGOT THERAPY; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; WOUND;

ANIMALS; APROTININ; BLOTTING, WESTERN; CHYMOTRYPSIN; DIPTERA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LARVA; SKIN; TRYPSIN INHIBITORS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 78650448723     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10081.x     Document Type: Article

References (14)

1. Sherman RA, Hall MJR, Thomas S,. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000; 45: 55-81. (Pubitemid 30187854)
2. Wollina U, Liebold K, Schmidt W, et al. Biosurgery supports granulation and debridement in chronic wounds-clinical data and remittance spectroscopy measurement. Int J Dermatol 2002; 41: 635-9. (Pubitemid 35252036)
3. Schmidtchen A, Wolff H, Rydengard V, Hansson C,. Detection of serine proteases secreted by Lucilia sericata in vitro and during treatment of a chronic leg ulcer. Acta Derm Venereol (Stockh) 2003; 83: 310-11. (Pubitemid 36920616)
4. Chambers L, Woodrow S, Brown AP, et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 2003; 148: 14-23. (Pubitemid 36114856)
5. Horobin AJ, Shakesheff KM, Woodrow S, et al. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol 2003; 148: 923-33. (Pubitemid 36750784)
6. Horobin AJ, Shakesheff KM, Pritchard DI,. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen 2005; 13: 422-33.
7. Horobin AJ, Shakesheff KM, Pritchard DI,. Promotion of human dermal fibroblast migration, matrix remodeling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata secretions. J Invest Dermatol 2006; 126: 1410-18.
8. Telford G, Brown AP, Seabra RAM, et al. Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericata. Br J Dermatol 2010; 163: 523-31.
9. Ascenzi P, Bocedi A, Bolognesi M, et al. The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. Curr Protein Pept Sci 2003; 4: 231-51. (Pubitemid 36656736)
10. Brantly M,. α1-antitrypsin: not just an antiprotease. Am J Respir Cell Mol Biol 2002; 27: 652-4.
11. Morii M, Travis J,. Amino acid sequence at the reactive site of human α1-antichymotrypsin. J Biol Chem 1983; 258: 12749-52.
12. Whitaker IS, Twine C, Whitaker MJ, et al. Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad Med J 2007; 83: 409-13. (Pubitemid 46960827)
13. Barrett AJ, Starkey PM,. The interaction of α2-macroglobulin with proteinases. Biochem J 1973; 133: 709-24.
14. Armstrong PB, Quigley JP,. α2-macroglobulin: an evolutionarily conserved arm of the innate immune system. Dev Comp Immunol 1999; 23: 375-90.